Literature DB >> 3069069

[Long-term course of hepatic glycogenosis. A retrospective study of 76 cases].

L de Parscau1, P Guibaud, P Labrune, M Odièvre.   

Abstract

In order to study the long term outcome of hepatic glycogen storage diseases, a national retrospective inquiry gathered 76 patients older than 12 years. In adolescents and adults, hypoglycemia, failure to thrive, pubertal delay, hepatomegaly and metabolic disturbances are major in type I, intermediary in type III and mild in type "VI+IX". Spontaneous improvement of these symptoms is noted in older patients. Beside these classical signs, anemia, high blood pressure, renal failure and persistent hypercholesterolemia were reported in some type I glycogen storage disease and bad school and professional results in type III. The knowledge of these complications should lead to a better management of these patients.

Entities:  

Mesh:

Year:  1988        PMID: 3069069

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  5 in total

1.  First trimester prenatal diagnosis of glycogen storage disease type III.

Authors:  I Maire; G Mandon; M Mathieu
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Glycogen storage disease type 1a in three siblings with the G270V mutation.

Authors:  R Parvari; J Isam; S W Moses
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

3.  Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients.

Authors:  P Labrune; P Huguet; M Odievre
Journal:  Pediatr Cardiol       Date:  1991-07       Impact factor: 1.655

Review 4.  The hepatic glycogen storage diseases--problems beyond childhood.

Authors:  P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 5.  Glucose-6-phosphatase deficiency.

Authors:  Roseline Froissart; Monique Piraud; Alix Mollet Boudjemline; Christine Vianey-Saban; François Petit; Aurélie Hubert-Buron; Pascale Trioche Eberschweiler; Vincent Gajdos; Philippe Labrune
Journal:  Orphanet J Rare Dis       Date:  2011-05-20       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.